68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Vertex Pharmaceuticals Incorporated revenue reports

Vertex Pharmaceuticals Incorporated financial reports, Vertex Pharmaceuticals Incorporated annual revenue in 2019. When does Vertex Pharmaceuticals Incorporated report revenue?
Add to widgets
Added to widgets
Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 858 435 000 $ +33.96 % ↑ 268 631 000 $ +27.76 % ↑
31/12/2018 870 106 000 $ +33.53 % ↑ 1 550 527 000 $ +1 439.990 % ↑
30/09/2018 784 535 000 $ +35.69 % ↑ 128 746 000 $ -
30/06/2018 752 157 000 $ +38.23 % ↑ 207 360 000 $ +1 052.260 % ↑
31/03/2018 640 799 000 $ - 210 263 000 $ -
31/12/2017 651 634 000 $ - 100 684 000 $ -
30/09/2017 578 165 000 $ - -102 952 000 $ -
30/06/2017 544 135 000 $ - 17 996 000 $ -
Show:
to

Vertex Pharmaceuticals Incorporated financial report charts

Vertex Pharmaceuticals Incorporated quarterly report dates

31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
423 853 000 $ 309 936 000 $ 342 770 000 $ 310 243 000 $ 569 186 000 $ 567 582 000 $ 505 291 000 $ 472 930 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
434 582 000 $ 560 170 000 $ 441 765 000 $ 441 914 000 $ 71 613 000 $ 84 052 000 $ 72 874 000 $ 71 205 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
858 435 000 $ 870 106 000 $ 784 535 000 $ 752 157 000 $ 640 799 000 $ 651 634 000 $ 578 165 000 $ 544 135 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
858 435 000 $ 870 106 000 $ 784 535 000 $ 752 157 000 $ 637 729 000 $ 621 228 000 $ 549 642 000 $ 513 988 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
276 808 000 $ 156 726 000 $ 205 475 000 $ 172 940 000 $ 128 825 000 $ 126 124 000 $ -70 366 000 $ 56 230 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
268 631 000 $ 1 550 527 000 $ 128 746 000 $ 207 360 000 $ 210 263 000 $ 100 684 000 $ -102 952 000 $ 17 996 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - 310 553 000 $ 306 664 000 $ 454 947 000 $ 289 451 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
581 627 000 $ 713 380 000 $ 579 060 000 $ 579 217 000 $ 440 361 000 $ 441 458 000 $ 575 657 000 $ 416 700 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
4 183 039 000 $ 3 843 109 000 $ 3 686 611 000 $ 3 407 423 000 $ 3 041 116 000 $ 2 648 963 000 $ 2 327 974 000 $ 2 180 572 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
6 543 114 000 $ 6 245 898 000 $ 4 620 840 000 $ 4 335 386 000 $ 3 952 974 000 $ 3 546 014 000 $ 3 198 325 000 $ 3 285 594 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
2 893 885 000 $ 2 650 134 000 $ 2 478 302 000 $ 2 145 359 000 $ 2 005 728 000 $ 1 665 412 000 $ 1 384 966 000 $ 1 223 130 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
1 106 468 000 $ 1 120 292 000 $ 992 508 000 $ 927 300 000 $ 16 919 000 $ 22 531 000 $ 19 881 000 $ 18 179 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - 2 477 017 000 $ 2 088 666 000 $ 1 812 248 000 $ 1 668 650 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
1 819 801 000 $ 1 810 695 000 $ 1 686 359 000 $ 1 620 503 000 $ 595 125 000 $ 606 433 000 $ 587 191 000 $ 568 544 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
27.81 % 28.99 % 36.49 % 37.38 % 15.06 % 17.10 % 18.36 % 17.30 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
4 723 313 000 $ 4 435 203 000 $ 2 906 116 000 $ 2 686 228 000 $ 2 401 056 000 $ 2 028 579 000 $ 1 791 077 000 $ 1 671 273 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
324 784 000 $ 314 578 000 $ 381 348 000 $ 321 703 000 $ 252 657 000 $ 227 511 000 $ 170 086 000 $ 181 653 000 $

Last revenue report of Vertex Pharmaceuticals Incorporated was 31/03/2019. According to last financial report total revenue in Vertex Pharmaceuticals Incorporated was 858 435 000 US dollar and changed by +33.96% since last year. Net income in Vertex Pharmaceuticals Incorporated was 268 631 000 $ in last quartal, net income changes to +27.76%.

Vertex Pharmaceuticals Incorporated stocks data

Vertex Pharmaceuticals Incorporated financials